Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

135.23 (USD) • At close July 30, 2025
Bedrijfsnaam Ligand Pharmaceuticals Incorporated
Symbool LGND
Munteenheid USD
Prijs 135.23
Beurswaarde 2,609,154,666
Dividendpercentage 0%
52-weken bereik 90.29 - 143.13
Industrie Biotechnology
Sector Healthcare
CEO Mr. Todd C. Davis Ph.D.
Website https://www.ligand.com

An error occurred while fetching data.

Over Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis;

Vergelijkbare Aandelen

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

107.88 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

41.96 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

2.56 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

153.22 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

15.48 USD

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

30.77 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

3.04 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

11.17 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)